Sponsor Pipeline

Cerus Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03037164 INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus… Anemia Active, Not Recruiting
Phase 2
NCT07015437 A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the… Healthy Subjects Recruiting
NCT07152379 Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects… Transfusion Reaction, Hemolytic Not Yet Recruiting
Not specified
NCT07218185 Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated… Hypofibrinogenemia Not Yet Recruiting
Get alerts when Cerus Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free